Semaglutide activates glucagon-like peptide-1 receptors throughout your digestive system, which slows stomach emptying and reduces hunger signalsbut this same mechanism can trigger nausea, vomiting, and constipation in up to 40% of users during initial dose escalation
Intramuscular injections bypass the gastrointestinal tract, delivering B12 directly into the bloodstream and producing faster results than oral preparations
Generally, current treatments of IC are solely concerned with symptomatic relief of the condition, with the most effective course of treatment for the disease yet to be confirmed through continuing clinical trials designed to amplify the knowledge of the causative factors of IC, as well as to enhance the treatment regime (Lukban, 2003
Adv Drug Delivery Rev 42:225238 Lewis AL, Mcentee N, Holland J, Patel A (2022) Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
Irritability could result from low blood sugar (hypoglycemia), changes in appetite, dehydration, gastrointestinal side effects, or hormonal fluctuations due to weight loss
As with all medications, Semaglutide GLP-1 injections come with side effects and should only be used at the recommendation of a medical professional and exactly as prescribed